Progression free survival (PFS) according to the dynamics of the results of QIP-MS and NGF at the 4 time points analyzed. Landmark analyses of PFS from postconsolidation to biochemical/clinical progression or death of patients included in GEM12MENOS65 trial based on QIP-MS (A) or NGF (B) dynamics from postinduction to postconsolidation. Landmark analyses of PFS from 24 cycles of maintenance to biochemical/clinical progression or death of patients included in GEM14MAIN trial based on QIP-MS (C) or NGF (D) dynamics from enrollment to 24 cycles of maintenance.